World federation of societies of biological psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders

About this resource

OBJECTIVES: The treatment of eating disorders is a complex process that relies not only on the use of psychotropic drugs but should include also nutritional counselling, psychotherapy and the treatment of the medical complications, where they are present. In this review recommendations for the pharmacological treatment of eating disorders (anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED)) are presented, based on the available literature. METHODS: The guidelines for the pharmacological treatment of eating disorders are based on studies published between 1977 and 2010. A search of the literature included: anorexia nervosa bulimia nervosa, eating disorder and binge eating disorder. Many compounds have been studied in the therapy of eating disorders (AN: antidepressants (TCA, SSRIs), antipsychotics, antihistaminics, prokinetic agents, zinc, Lithium, naltrexone, human growth hormone, cannabis, clonidine and tube feeding; BN: antidepressants (TCA, SSRIs, RIMA, NRI, other AD), antiepileptics, odansetron, d-fenfluramine Lithium, naltrexone, methylphenidate and light therapy; BED: antidepressants (TCA, SSRIs, SNRIs, NRI), antiepileptics, baclofen, orlistat, d-fenfluramine, naltrexone). RESULTS: In AN 20 randomized controlled trials (RCT) could be identified. For zinc supplementation there is a grade B evidence for AN. For olanzapine there is a category grade B evidence for weight gain. For the other atypical antipsychotics there is grade C evidence. In BN 36 RCT could be identified. For tricyclic antidepressants a grade A evidence exists with a moderate-risk-benefit ratio. For fluoxetine a category grade A evidence exists with a good risk-benefit ratio. For topiramate a grade 2 recommendation can be made. In BED 26 RCT could be identified. For the SSRI sertraline and the antiepileptic topiramate a grade A evidence exists, with different recommendation grades. CONCLUSIONS: Additional research is needed for the improvement of the treatment of eating disorders. Especially for anorexia nervosa there is a need for further pharmacological treatment strategies.

AuthorAigner, Martin; Treasure, Janet; Kaye, Walter & Kasper, Siegfried
JournalWorld Journal of Biological Psychiatry
Volume12(6):400-443
Year2011

See also

Insights in Recovery: A consumer-informed guide for health practitioners working with people with eating disorders

Gaining insight into consumer experience is essential for effective implementation of mental health recovery policy.

Read more

AED Eating Disorders: A Guide to Medical Care (4th Ed.)

Often referred to as, the purple book, this guide from the Academy for Eating Disorders' (AED) Medical Care Standards Committee, is intended as a resource to promote recognition and risk management in the care of those with eating disorders.

Read more

Guidelines for the Inpatient Management of Adult Eating Disorders in General Medical and Psychiatric Settings in NSW

This document is designed to be used by nurses, doctors, allied health and general health staff located in hospitals or wards without specialist eating disorder facilities, to guide in the assessment of eating disorders, indicators for admission, and management strategies.

Read more

QuEDS Guide to Admission and Inpatient Treatment

The Guide to Admission and Inpatient Treatment has been developed by the Queensland Eating Disorder Service (QuEDS) and is supported by current literature, research, and expert opinion.

Read more